跳至主要内容
临床试验/CTRI/2023/10/058966
CTRI/2023/10/058966招募中4 期

Comparison of Ketamine Vs Lignocaine intravenous infusion in refractory cancer pain - NI

Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with Refractory cancer pain with NRS >6-7/10 despite optimal opioid drugs (OME
  • >300 mg / day)
  • Patients with refractory neuropathic/mixed pain Patients with life span >8weeks

排除标准

  • H/O psychosis
  • Any liver, kidney and heart abnormalities Patients with altered cognitive function
  • H/O drugs hypersensitivity
  • Patients not giving consent

研究者

发起方
Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad

相似试验